Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).

Mothe B. et al, (2019), EClinicalMedicine, 11, 65 - 80

MS-Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments.

Andreatta M. et al, (2019), Proteomics, 19

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

López-Camacho C. et al, (2018), Nature Communications, 9

Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers

Rosás-Umbert M. et al, (2018), Journal of Virology, 93

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

Martin GE. et al, (2018), Frontiers in Immunology, 9

Therapeutic HPV vaccines

Hancock G. et al, (2018), Best Practice & Research Clinical Obstetrics & Gynaecology, 47, 59 - 72

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.

Hartnell F. et al, (2018), Frontiers in immunology, 9

Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.

Yang H. et al, (2018), Front Immunol, 9

Pathophysiology of ischaemic heart disease

Pocock MO. et al, (2017), Current Opinion in HIV and AIDS, 12, 548 - 553

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens

Moyo N. et al, (2017), PLOS ONE, 12, e0181382 - e0181382

Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines

Borthwick N. et al, (2017), PLOS ONE, 12, e0176418 - e0176418

Recent advances in understanding and preventing human papillomavirus-related disease

Hellner K. and Dorrell L., (2017), F1000Research, 6, 269 - 269

Detecting asymptomatic Trichomonas vaginalis in females using the BD ProbeTec™ Trichomonas vaginalis Qx nucleic acid amplification test

Lord E. et al, (2017), International Journal of STD & AIDS, 28, 357 - 361

Discovery of a PCAF Bromodomain Chemical Probe

Moustakim M. et al, (2017), Angewandte Chemie International Edition, 56, 827 - 831

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects

Hancock G. et al, (2017), Journal of the International AIDS Society, 20, 21171 - 21171

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

Yang H. et al, (2016), Molecular Therapy, 24, 1913 - 1925

Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells

Wallace ZR. et al, (2016), Antiviral Research, 133, 178 - 182

Viral vectors as vaccine platforms: from immunogenicity to impact

Ewer KJ. et al, (2016), Current Opinion in Immunology, 41, 47 - 54

HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema

Ntusi N. et al, (2016), Circulation: Cardiovascular Imaging, 9

Control of HIV-1 replication in vitro by vaccine-induced human CD8+ T cells through conserved subdominant Pol epitopes

Ahmed T. et al, (2016), Vaccine, 34, 1215 - 1224

Load More

1
2
3
4
5

Include forthcoming?